Suppr超能文献

出血性疾病、月经过多和缺铁:对健康相关生活质量的影响。

Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life.

机构信息

Centre for Health Economics and Policy Analysis, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.

出版信息

Haemophilia. 2013 May;19(3):385-91. doi: 10.1111/hae.12014. Epub 2012 Sep 21.

Abstract

von Willebrand disease (VWD) is a bleeding disorder that occurs in up to 1% of the general population. The great majority of females with VWD experience menorrhagia. The morbidity burden in females with VWD may relate to iron deficiency resulting from menorrhagia. To explore relationships between bleeding disorders, menorrhagia, iron deficiency and the outcomes of health-related quality of life (HRQL) and educational attainment. All subjects with VWD, and females with other bleeding disorders, in the Canadian national registry who were more than 12 years of age were eligible for survey. Survey measures included the HEALTH UTILITIES INDEX(®); abridged Clinical History Assessment Tool; socio-demographic questions and serum ferritin. Statistical analyses included testing differences among groups of means using analysis of variance and of proportions using chi-squared test. Significant size differences in mean HRQL scores were detected between VWD females and both females with other bleeding disorders [diff = (-0.08); P = 0.017] and VWD males [diff = (-0.07); P = 0.039]. Mean HRQL scores differed between females with and without menorrhagia (P < 0.001). Mean HRQL scores were not significantly different between females with and without iron deficiency. Educational attainment was not associated with disease group, menorrhagia status or iron status. Females with VWD have a greater morbidity burden than females in the general population, females with other bleeding disorders and males with VWD. Menorrhagia is associated with low HRQL scores in females with bleeding disorders, including VWD. Further investigation should assess how menorrhagia impacts HRQL in females with bleeding disorders.

摘要

血管性血友病(VWD)是一种出血性疾病,在普通人群中的发病率高达 1%。大多数患有 VWD 的女性都经历过月经过多。患有 VWD 的女性的发病率负担可能与月经过多导致的缺铁有关。为了探讨出血性疾病、月经过多、缺铁与健康相关生活质量(HRQL)和教育程度的结果之间的关系。加拿大国家登记处所有年龄超过 12 岁的 VWD 患者和其他出血性疾病的女性患者都有资格接受调查。调查措施包括健康效用指数(®);简化临床病史评估工具;社会人口统计学问题和血清铁蛋白。统计分析包括使用方差分析测试组间均值的差异,使用卡方检验测试组间比例的差异。VWD 女性与其他出血性疾病女性[差异=(-0.08);P=0.017]和 VWD 男性[差异=(-0.07);P=0.039]之间的平均 HRQL 评分存在显著差异。有和没有月经过多的女性之间的平均 HRQL 评分存在差异(P<0.001)。有和没有缺铁的女性之间的平均 HRQL 评分没有显著差异。教育程度与疾病组、月经过多状况或铁状况无关。VWD 女性的发病率负担大于普通人群中的女性、其他出血性疾病女性和 VWD 男性。月经过多与出血性疾病女性(包括 VWD)的低 HRQL 评分相关。进一步的研究应该评估月经过多如何影响出血性疾病女性的 HRQL。

相似文献

1
Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life.
Haemophilia. 2013 May;19(3):385-91. doi: 10.1111/hae.12014. Epub 2012 Sep 21.
2
Health status and health-related quality of life associated with von Willebrand disease.
Am J Hematol. 2003 Jun;73(2):108-14. doi: 10.1002/ajh.10327.
3
Prevalence of von Willebrand disease in women with iron deficiency anaemia and menorrhagia in Taiwan.
Haemophilia. 2008 Jul;14(4):768-74. doi: 10.1111/j.1365-2516.2008.01777.x. Epub 2008 May 17.
4
von Willebrand disease and bleeding in women.
Haemophilia. 1999 Sep;5(5):313-7. doi: 10.1046/j.1365-2516.1999.00342.x.
5
Quality of life in women with bleeding disorders.
Haemophilia. 2011 Jul;17 Suppl 1:33-7. doi: 10.1111/j.1365-2516.2011.02563.x.
6
Cost-utility analysis of von Willebrand disease screening in adolescents with menorrhagia.
J Pediatr. 2010 Sep;157(3):456-60, 460.e1. doi: 10.1016/j.jpeds.2010.03.009. Epub 2010 May 6.
9
The condensed MCMDM-1 VWD bleeding questionnaire as a predictor of bleeding disorders in women with unexplained menorrhagia.
Blood Coagul Fibrinolysis. 2012 Jun;23(4):311-5. doi: 10.1097/MBC.0b013e32835274d9.
10
[Appropriate laboratory investigation in women with menorrhagia].
J Gynecol Obstet Biol Reprod (Paris). 2008 Dec;37 Suppl 8:S317-28. doi: 10.1016/S0368-2315(08)74771-9.

引用本文的文献

1
A qualitative study on the impact of bleeding disorders on the daily life of Dutch women.
Womens Health (Lond). 2025 Jan-Dec;21:17455057251362582. doi: 10.1177/17455057251362582. Epub 2025 Aug 17.
2
Prevalence of heavy menstrual bleeding, iron deficiency, iron deficiency anemia, and treatment in women with von Willebrand disease-a cohort study.
Res Pract Thromb Haemost. 2025 Jun 20;9(4):102949. doi: 10.1016/j.rpth.2025.102949. eCollection 2025 May.
3
The detrimental impact of ferritin "normal" ranges on diagnosis of bleeding disorders in women.
Res Pract Thromb Haemost. 2025 Jan 7;9(1):102674. doi: 10.1016/j.rpth.2024.102674. eCollection 2025 Jan.
4
Evaluating the impact of the self-BAT screening tool on patient outcomes: Results of the let's talk period project.
Haemophilia. 2024 Nov;30(6):1400-1405. doi: 10.1111/hae.15113. Epub 2024 Nov 15.
5
Bleeding and quality of life in people with Glanzmann thrombasthenia-insights from the Glanzmann's 360 study.
Res Pract Thromb Haemost. 2024 Oct 9;8(7):102586. doi: 10.1016/j.rpth.2024.102586. eCollection 2024 Oct.
6
von Willebrand disease.
Nat Rev Dis Primers. 2024 Jul 25;10(1):51. doi: 10.1038/s41572-024-00536-8.
7
Pharmacologically Treated Anxiety and Depression in People Diagnosed with von Willebrand Disease: Matched Cohort Study.
J Blood Med. 2023 Jul 11;14:413-425. doi: 10.2147/JBM.S407993. eCollection 2023.
8
Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias.
Res Pract Thromb Haemost. 2023 Apr 24;7(4):100161. doi: 10.1016/j.rpth.2023.100161. eCollection 2023 May.
9
Management of heavy menstrual bleeding in women with bleeding disorders in a tertiary care center.
Res Pract Thromb Haemost. 2023 Mar 13;7(3):100119. doi: 10.1016/j.rpth.2023.100119. eCollection 2023 Mar.
10
Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review.
J Blood Med. 2023 Mar 2;14:189-208. doi: 10.2147/JBM.S389241. eCollection 2023.

本文引用的文献

1
Quality of life in women with bleeding disorders.
Haemophilia. 2011 Jul;17 Suppl 1:33-7. doi: 10.1111/j.1365-2516.2011.02563.x.
2
Impact of von Willebrand disease on health-related quality of life in a pediatric population.
J Thromb Haemost. 2011 Mar;9(3):502-9. doi: 10.1111/j.1538-7836.2010.04175.x.
3
Health-related quality of life among adult patients with moderate and severe von Willebrand disease.
J Thromb Haemost. 2010 Jul;8(7):1492-9. doi: 10.1111/j.1538-7836.2010.03864.x. Epub 2010 Mar 23.
4
Applying diagnostic criteria for type 1 von Willebrand disease to a pediatric population.
Pediatr Blood Cancer. 2009 Jan;52(1):102-7. doi: 10.1002/pbc.21755.
5
von Willebrand disease update: diagnostic and treatment dilemmas.
Haemophilia. 2008 Jul;14 Suppl 3:56-61. doi: 10.1111/j.1365-2516.2008.01713.x.
7
Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease.
J Thromb Haemost. 2007 Jun;5(6):1165-9. doi: 10.1111/j.1538-7836.2007.02563.x.
8
Health-related quality of life among Japanese women with iron-deficiency anemia.
Qual Life Res. 2006 Dec;15(10):1559-63. doi: 10.1007/s11136-006-0030-z. Epub 2006 Jul 7.
9
Testing for von Willebrand disease in women with menorrhagia: a systematic review.
Obstet Gynecol. 2004 Aug;104(2):381-8. doi: 10.1097/01.AOG.0000133487.55682.7b.
10
Bleeding risks associated with inheritance of the Quebec platelet disorder.
Blood. 2004 Jul 1;104(1):159-65. doi: 10.1182/blood-2003-11-4077. Epub 2004 Mar 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验